Appian Cl A had its Relative Strength (RS) Rating upgraded from 77 to 83 Wednesday.
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over the trailing 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the best-performing stocks typically have an RS Rating north of 80 as they launch their biggest climbs.
Risk Management In The Stock Market: How Much Money To Invest Now
Appian Cl A has moved more than 5% past a 35.99 entry in a first-stage cup with handle, meaning it's now out of a proper buy range. Look for the stock to offer a new chance to get in like a three-weeks tight or pullback to the 50-day or 10-week line.
Appian Cl A posted 0% earnings growth last quarter. Revenue increased 15%. The next quarterly results are expected on or around Nov. 7.
The company earns the No. 7 rank among its peers in the Computer Software-Design industry group. Autodesk, Altair Engineering Cl A and Cadence Design Systems are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
